Excessive Green Tea Intake Alters Hemoglobin (Hb) Concentration and Histoarchitecture of Liver

A myriad of health claims are being made in favor of the consumption of green tea due to its easy availability and greater popularity. On the contrary, certain health risks of excessive green tea consumption have begun to emerge. The aim of the present research was to observe the baleful effects of excessive green tea intake on hematological parameter and histoarchitecture of liver. A total of thirty (n=30) Swiss albino mice were taken and randomly divided into Control C, Treated T1, and Treated T2 groups. Each group consisted of ten (5 male+5 female) mice. The Control C group was fed with normal mice pellet and water (3ml/mice) orally but the treated T1 group was supplied mice pellet with 2ml/mice of green tea+1ml/mice of water orally as well as treated T2 group was given mice pellet and 3ml/mice of green tea orally two times in a day for 60 days. After the experimental tenure, mice of each group were sacrificed ethically and samples (Blood, liver and lungs) were collected for further hematological and histomorphological studies. Treated T2 group of mice were motionless (inactive and stagnant). Anatomopathologically, the liver surface became dark red in color with considerable hepatomegaly and mild hemorrhage also found on lung surface. Histologically, mild central vein congestion and severe venous congestion with dilation were found in the portal vein of the liver of the treated T2 group of mice. Hematologically, hemoglobin level significantly reduced in the treated T2 group of mice than the others. Within this experimental period, female mice of each group gave birth (15-18 pups) that were devoid of any abnormality. Therefore, it can be concluded that excessive green tea intake in a day might have baleful effects on hematological parameter (Hb concentration) and histoarchitechture of liver in Swiss albino mice.

PDF

___

lschuler L.1998. Green tea: healing tonic. Am. J. Natur. Med., 5:28-31.
Augustyniak A, Waszkiewicz E, Skrzydlewska E.2005. Preventive action of green tea from changes in the liver antioxidant abilities of different aged rats intoxicated with ethanol. Nutrition, 21(9):925-32.
Biswas KP.2006. Description of tea plant. Encyclopaedia of Medicinal Plants, 964-6.
Bursill CA, Abbey M, Roach PD.2007. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis, 193(1):86-93.
Cabrera C, Artacho R, Giménez R.2006. Beneficial effects of green tea—a review. Journal of the American College of Nutrition. 25(2):79-99.
Cavalli L, Tavani A. 2016. Coffee consumption and its impact on health. InBeverage Impacts on Health and Nutrition. Humana Press, Cham, pp. 29-47.
Chang PY, Mirsalis J, Riccio ES, Bakke JP, Lee PS, Shimon J, Phillips S, Fairchild D, Hara Y, Crowell JA.2003.
Genotoxicity and toxicity of the potential cancer preventive agent polyphenon E. Environmental and molecular mutagenesis, 41(1):43-54.
Cooper R, Morré DJ, Morré DM.2005. Medicinal benefits of green tea: Part I. Review of noncancer health benefits. Journal of Alternative & Complementary Medicine, 11(3):521-8.
Daniells S.2008. Green tea shows benefits against fatty liver. Journal of Nutrition, 138:323.
El Daly AA.2011. Effect of Green Tea Extract on the Rat Liver; Histo-architectural, Histochemical and Ultrastructural Studies. Journal of American Science. 7(5):65-73.
Fan FS.2016. Iron deficiency anemia due to excessive green tea drinking. Clinical case reports. 4(11):1053.
Frank J, George TW, Lodge JK, Rodriguez-Mateos AM, Spencer JP, Minihane AM, Rimbach G.2009. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. The Journal of nutrition. 139(1):58-62.
Fung ST, Ho CK, Choi SW, Chung WY, Benzie IF.2013. Comparison of catechin profiles in human plasma and urine after single dosing and regular intake of green tea (Camellia sinensis). British journal of nutrition, 9(12):2199-207.
Galati G, Lin A, Sultan AM, O'Brien PJ.2006. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radical Biology and Medicine. 40(4):570-80.
Higdon JV, Frei B.2006. Coffee and health: a review of recent human research. Critical reviews in food science and nutrition, 46(2):101-23.
Hirai M, Hotta Y, Ishikawa N, Wakida Y, Fukuzawa Y, Isobe F, Nakano A, Chiba T, Kawamura N.2007. Protective effects of EGCg or GCg, a green tea catechinepimer, against postischemic myocardial dysfunction in guinea-pig hearts. Life sciences, 80(11):1020-32.
Jimenez-Saenz M & Del Carmen Martinez-Sanchez M.2006. Acute hepatitis associated with the use of green tea infusions. J Hepatol, 44(3): 616-617.
Jin X, Zheng RH, Li YM.2008. Green tea consumption and liver disease: a systematic review. Liver international, 28(7):990- 6.
Jin Y, Jin CH, Ho Row K.2006. Separation of catechin compounds from different teas. Biotechnology Journal: Healthcare Nutrition Technology, (2):209-13.
Kuriyama S.2008. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. The Journal of nutrition, 138(8):1548S-53S.
Kundu SK, Das SK, Sohidullah M. 2021. Green Tea: Conventional Facts and its Frontier Prospect on Health-A review. Turkish Journal of Agriculture-Food Science and Technology. 9(6):1222-5.
Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS.2010. Hepatotoxicity of high oral dose (−)-epigallocatechin-3- gallate in mice. Food and chemical toxicology. 48(1):409-16.
Lantika UA, Damailia R, Bhatara T, Ekowati RR, Yulianti AB.2020. The impact of purple sweet potato water extract on excess weight gain in pregnant mice. InMedical Technology and Environmental Health, (pp. 14-18). CRC Press.
Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK.2005. Phase I study of green tea extract in patients with advanced lung cancer. Cancer chemotherapy and pharmacology. 55(1):33-8.
Liao S.2001. The medicinal action of androgens and green tea epigallocatechingallate. Hong Kong medical journal= Xianggangyixuezazhi, 7(4):369-74.
Liu J, Xing J, Fei Y.2008. Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies. Chinese medicine. 3(1):1-7.
Lou YR, Lu YP, Xie JG, Huang MT, Conney AH.1999. Effects of oral administration of tea, decaffeinated tea, and caffeine on the formation and growth of tumors in high-risk SKH-1 mice previously treated with ultraviolet B light. Nutrition and cancer, 33(2):146-53.
Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S.2009. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. European journal of clinical pharmacology. 65(4):331- 41.
McCormick DL, Johnson WD, Morrissey RL, Crowell JA.1999. Subchronic oral toxicity of epigallocatechingallate (EGCG) in rats and dogs. Toxicol Sci, 48:57.
Merck.2005. "Diabetes mellitus". Merck Veterinary Manual. 9th edition.
Navarro-Perán E, Cabezas-Herrera J, García-Cánovas F, Durrant MC, Thorneley RN, Rodríguez-López JN.2005. The antifolate activity of tea catechins. Cancer research, 65(6):2059-64.
Nawab A, Farooq N.2015. Review on green tea constituents and its negative effects. The Pharma Innovation.4(1, Part A):21.
Nelson M, Poulter J.2004. Impact of tea drinking on iron status in the UK: a review. Journal of Human Nutrition and Dietetics, 17(1):43-54.
Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, Glisson BS, Lee JS.2001. Phase I trial of oral green tea extract in adult patients with solid tumors. Journal of Clinical Oncology, 19(6):1830-8.
Prystai, E., Kies, C. and Driskell, J. 1999. Calcium, copper, iron, magnesium and zinc utilization of humans as affected by consumption of black, decaffeinated black and green teas. Nutr. Res, 19:167–177.
Ross IA.2005. Tea common names and its uses. Medicinal Plants of the World, 3:1-9.
Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI, Dog TL.2008. Safety of green tea extracts. Drug safety, 31(6):469-84.
Schönthal AH.2011. Adverse effects of concentrated green tea extracts. Molecular nutrition & food research, 55(6):874-85.
Sengottuvelu S, Duraisami S, Nandhakumar J, Duraisami R, Vasudevan M.2008. Hepatoprotective activity of Camellia sinensis and its possible mechanism of action. IJPT,7: 9-14.
Shareef SH, Ibrahim IA, Alzahrani AR, Al-Medhtiy MH, Abdulla MA.2021. Hepatoprotective effects of methanolic extract of green tea against Thioacetamide-Induced liver injury in Sprague Dawley rats. Saudi Journal of Biological Sciences.
Singh BN, Shankar S, Srivastava RK.2011. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical pharmacology, 82(12):1807-21.
Sinija VR, Mishra HN.2008. Green tea: Health benefits. Journal of Nutritional & Environmental Medicine,17(4):232-42.
Stratton SP, Bangert JL, Alberts DS, Dorr RT.2000. Dermal toxicity of topical (−) epigallocatechin-3-gallate in BALB/c and SKH1 mice. Cancer letters,158(1):47-52.
Tomasulo P.2004. Natural Medicines Database http://www. naturaldatabase. com. Journal of consumer health on the internet, 8(2):75-85.
Ui A, Kuriyama S, Kakizaki M, Sone T, Nakaya N, Ohmori- Matsuda K, Hozawa A, Nishino Y, Tsuji I.2009. Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study. Cancer Causes & Control, 20(10):1939-45.
Van Het Hof KH, Wiseman SA, Yang CS, Tijburg LB.1999. Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proceedings of the Society for Experimental Biology and Medicine, 20(4):203-9.
Wang D, Wang Y, Wan X, Yang CS, Zhang J.2015. Green tea polyphenol (−)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: Responses of major antioxidant enzymes and the Nrf2 rescue pathway. Toxicology and applied pharmacology, 283(1):65-74.
Yoshida M, Takahashi M, Inoue K, Nakae D, Nishikawa A.2011. Lack of chronic toxicity and carcinogenicity of dietary administrated catechin mixture in Wistar Hannover GALAS rats. The Journal of toxicological sciences, 36(3):297-311.